re-set tabl rais pt
adjust revenu guidanc in-lin
high end guidanc repres around underli growth
adjust fx revenu recognit loss biolog market fee
ep estim top end
guidanc exhibit base presum tax rate follow
us re-domicil revis rev/ep estimate
rais dcf base pt
invest thesi valuat risk believ
near complet re-set tabl refurbish
product portfolio optim sale footprint attain
reason long term tax rate take advantag recent us tax
reform law re-domicil us mid-term feel bone
stimul busi continu chug along mid-singl digit rang
benefit ofix strong insur sale infrastructur nass
guidelin chang continu evid develop franchis
like continu enjoy posit msd momentum due continu
refresh/augment product line especi extrem fixat
spinal fixat optim sale channel complet
captur address market product refresh synergist
importantli enabl gain mindshar distributor network
believ combin initi offer least year remain
runway also believ improv gross margin
inventory/instru manag well product refresh reduct
 adjust ebitda improv per year year
final estim tax rate reduc
beyond re-domicil us assumpt dcf base
valuat rise discount rate termin growth
end risk stori includ consolid
spine fixat biolog market toward larger manufactur
may greater contract clout also offer robotics/navig
expens distributor segment play remot
chanc down-classif spinal bone stimul
major player miss-step undertaken enter faster
continu pg
tr target
note sbu restat new revenu recognit compani file factset strh estim
page
strh estimatesconsensusstrh vs consensu cc statementstrh estimatesconsensusstrh vs consensu cc sg incom adj estimatesconsensusstrh vs consensusmargin orthofix intern
page
except per share oper incom loss interest tax net adjust ep average share gaap continu pre-tax incom cont ep gaap averag share adjust ebitda expens margin analysi margin oper ebitda profit expens growth analysi yr/yr total revenu revenu cc ex-discontinu revenu cc fixat fixat oper incom orthofix intern
lead manufactur bone growth stimul product enhanc fusion rate
spine long bone fractur compani also sell spinal extrem implant use stabil
believ near complet re-set tabl refurbish
product portfolio optim sale footprint attain reason long
term tax rate take advantag recent us tax reform law re-domicil us mid-
term feel bone stimul busi continu chug along mid-singl digit
rang benefit ofix strong insur sale infrastructur nass guidelin chang
continu evid develop franchis like continu enjoy posit msd
momentum due continu refresh/augment product line especi extrem fixat
spinal fixat optim sale channel complet captur address
market product refresh synergist importantli enabl gain mindshar
distributor network believ combin initi offer least year remain
runway also believ improv gross margin inventory/instru
manag well product refresh reduct adjust ebitda improv
per year year final estim tax rate reduc
beyond re-domicil us
valuat risk
dcf base pt assum wacc termin growth rate risk stori includ
consolid spine fixat biolog market toward larger manufactur
may greater contract clout also offer robotics/navig expens
distributor segment play remot chanc down-classif spinal
bone stimul major player miss-step undertaken
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
